[
  {
    "ts": "2025-08-08T15:19:00+00:00",
    "headline": "Intellia Q2 Loss Narrower Than Expected, Pipeline Progress in Focus",
    "summary": "NTLA posts narrower Q2 loss and beats on revenues, while advancing phase III studies for ATTR and HAE programs.",
    "url": "https://finance.yahoo.com/news/intellia-q2-loss-narrower-expected-151900271.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "022e3174-18b1-3c00-8abe-4eb3b99edc54",
      "content": {
        "id": "022e3174-18b1-3c00-8abe-4eb3b99edc54",
        "contentType": "STORY",
        "title": "Intellia Q2 Loss Narrower Than Expected, Pipeline Progress in Focus",
        "description": "",
        "summary": "NTLA posts narrower Q2 loss and beats on revenues, while advancing phase III studies for ATTR and HAE programs.",
        "pubDate": "2025-08-08T15:19:00Z",
        "displayTime": "2025-08-08T15:19:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/4a85ded772dcf5689bab3fdbf2b5da21",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZiUXidurBfNGmOdrmp7WoA--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4a85ded772dcf5689bab3fdbf2b5da21.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g._u7aHnR8Tz9yGDeMpSaQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4a85ded772dcf5689bab3fdbf2b5da21.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/intellia-q2-loss-narrower-expected-151900271.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/intellia-q2-loss-narrower-expected-151900271.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-08T03:48:31+00:00",
    "headline": "BMO Capital Lifts PT on Regeneron Pharmaceuticals (REGN) Stock, Keeps Outperform",
    "summary": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the Most Undervalued Long Term Stocks to Buy According to Hedge Funds. On August 4, BMO Capital lifted the price target on the company’s stock to $640 from $600, while keeping an “Outperform” rating, as reported by The Fly. As per the analyst, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)’s healthy Q2 2025 […]",
    "url": "https://finance.yahoo.com/news/bmo-capital-lifts-pt-regeneron-034831592.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "e34adf53-3a86-376e-a7b7-669e625ccf23",
      "content": {
        "id": "e34adf53-3a86-376e-a7b7-669e625ccf23",
        "contentType": "STORY",
        "title": "BMO Capital Lifts PT on Regeneron Pharmaceuticals (REGN) Stock, Keeps Outperform",
        "description": "",
        "summary": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the Most Undervalued Long Term Stocks to Buy According to Hedge Funds. On August 4, BMO Capital lifted the price target on the company’s stock to $640 from $600, while keeping an “Outperform” rating, as reported by The Fly. As per the analyst, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)’s healthy Q2 2025 […]",
        "pubDate": "2025-08-08T03:48:31Z",
        "displayTime": "2025-08-08T03:48:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/9b67531d4ce9e2fbb21fef60675f48d3",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "BMO Capital Lifts PT on Regeneron Pharmaceuticals (REGN) Stock, Keeps Outperform",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xYTEe3VE6sgZxe9COOwZXw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/9b67531d4ce9e2fbb21fef60675f48d3.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ku0XeMdDvNCP8FVlwzrrCw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/9b67531d4ce9e2fbb21fef60675f48d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bmo-capital-lifts-pt-regeneron-034831592.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bmo-capital-lifts-pt-regeneron-034831592.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]